news

Dysfunctional B cells found to contribute to age-related metabolic disease

A study has shown that a group of cells called adipose B cells can become dysfunctional with age, causing metabolic conditions such as diabetes, which has provided a drug target.

A group of researchers has revealed why fat surrounding organs increases during ageing, providing a drug target for metabolic-related conditions such as diabetes. The study was conducted at Yale University, US.

Previous findings have shown that age reduces the body’s ability to burn fat, consequently leading to increased internal fat around elderly patients’ organs.

The current study demonstrated that the macrophage immune cells required to burn this fat remain active, but the overall numbers declined as fat increased with ageing.

 

Access your FREE copy

 


Biomarkers aren’t just supporting drug discovery – they’re driving it

FREE market report

From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.

What you’ll unlock:

  • How biomarkers are guiding dose selection and early efficacy decisions in complex trials
  • Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
  • What makes lab data regulatory-ready and why alignment matters from day one

Explore how biomarkers are shaping early drug development

Access the full report – it’s free!

 

Another finding from the investigation showed that adipose B cells in fat proliferate as animals age, contributing to increased inflammation and metabolic decline. According to the researchers, these adipose B cells are a unique source of inflammation; normally B cells produce antibodies but with ageing become dysfunctional.

…reducing macrophage signal and removing adipose B cells… protected against age-induced decline in metabolic health”

When working correctly, some B cells expand as needed to protect the body from infection, then contract to baseline. However, the aged cells do not contract.

“This predisposes an animal to diabetes and metabolic dysfunction like inability to burn fat,” said Dr Vishwa Deep Dixit, the lead researcher of the study. He theorised that this ongoing expansion may be due to increased human life expectancy, which pushes the body’s cells beyond their evolutionary limits. “Several mechanisms in the body are not selected for longevity,” he continued.

Using mice models, adipose B cells were found to expand by receiving signals from nearby macrophages. They also discovered that reducing macrophage signal and removing adipose B cells reversed the expansion process, which protected against age-induced decline in metabolic health.

A suggestion made by the researchers is to repurpose drugs to target these dysfunctional adipose B cells, such as cytokine IL-1B, which reduces one of the small proteins driving this process. Other immunotherapy drugs which neutralise B cells could also be a therapeutic option, say the team.

The results were published in Cell Metabolism.

Related conditions

Related organisations

Related people

Leave a Reply

Your email address will not be published. Required fields are marked *